3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
29
Lymphoma, Follicular
8
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma
7
Lymphoma, Non-Hodgkin
5
Leukemia, Lymphocytic, Chronic, B-Cell
4
Neoplasms
3
Smoldering Multiple Myeloma
2
Myelodysplastic Syndromes
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Burkitt Lymphoma
2
Recurrence
1
Neoplasms, Plasma Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
Vincristine
3
Doxorubicin
3
Dactinomycin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Radiotherapy, Conformal
2
Cyclophosphamide
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
cabozantinib
1
atezolizumab
1
Vemurafenib
1
Temozolomide
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Lenalidomide
×
30 days
×
Clear all
No trials found.